Almac Diagnostics is a global leader in the provision of translational genomic-based solutions for Pharma, biotech and academic customers. They specialise in working with fresh and formallin fixed paraffin embedded (FFPE) tissue for generation of predictive and prognostic tests, drug development, target identification and companion diagnostics. Almac Diagnostics also offer their own range of disease specific microarrays, "DSA™ research tools". Based on the GeneChip platform, these are the first high-density transcriptome based microarrays that focus on the transcriptome of a particular disease. ISO17025 accredited*
Althea Dx provides proprietary gene expression profiles including assays for differential diagnosis of pediatric cancers and for improved diagnosis and management of prostate cancer. Althea Dx has a track record of reducing the time, risk, and cost of drug development by providing biomarker discovery and development to biopharma clients and clinical testing services to physicians.
Asuragen™ Discovery & Clinical Research Services
Unique in the industry, Asuragen Services provides RNA/DNA sample prep and sample analysis services to meet the needs for the basic research, clinical research, and clinical development communities. Asuragen is a fully licensed service provider for Affymetrix. No other service provider has the industry-leading platforms combined with so many cumulative years of experience in RNA. We offer a wide range of services for quantification and data analysis of DNA, RNA and microRNA with sample prep services for FFPE, fresh tissues, blood, other biofluids, and cells. GLP compliant*
Cancer Genetics, Inc. (RTP, North Carolina)
Cancer Genetics, Inc. (RTP, North Carolina), a GLP compliant lab, is a global leader in pharmacogenomics services. With scientific expertise in assay design and development, sample management, genotyping, gene expression, tumor mutation profiling, microarray-based genomic services, bioinformatics, consulting, and biostorage, Gentris provides a full menu of services for its pharmaceutical and biotech clients.
Cogenics, Inc., a Clinical Data company, has consolidated the operations of Genaissance Pharmaceuticals, Inc., Lark Technologies, Inc., Icoria, Inc., and Genome Express SA to form a unique genomics services company that offers a comprehensive range of molecular biology and pharmacogenomics services to pharmaceutical, biotech, academic, and government clients. Cogenics has a proven record of scientific innovation and excellence in providing solutions-based services in support of research and development in genomics medicine and healthcare.
CLIA and GLP compliant*
Eurofins BioDiagnostics, Inc., a recognized leader in seed testing and molecular breeding services, offers a wide array of genomics and genotyping services to the seed industry. Using the most sophisticated platforms in genomic testing, our team of scientists specializing in agrigenomics, molecular breeding and bioinformatics provide the best service in the industry. Eurofins BioDiagnostics also offers a wide array of other seed testing services including genetic purity, trait purity, event identity, zygosity, adventitious presence, chemical analysis, germination, vigor, and physical purity besides the molecular breeding & genomic technology services. BioDiagnostics is ISO/IEC 17025:2005 accredited and is a USDA Accredited Seed Laboratory.
ExonHit Therapeutics is a world leader in the analysis of alternative RNA splicing, a biological process which when deregulated plays a key role in the onset of various diseases. Developed on the Affymetrix platform, ExonHit Therapeutic's SpliceArray™ is a platform technology that can be applied to drug target and gene signature biomarker discovery and development by detecting expression differences between multiple transcripts or isoforms that are generated from a single locus as a result of alternative splicing. ExonHit offers a comprehensive genomic service for clients to analyze your RNA samples on microarrays manufactured by Affymetrix to detect and differentiate splice variants based on our SpliceArray™ patented design approach.
Q2 Solutions – EA Genomics
EA is the industry leader in providing microarray-based genomic services for clinical trials using Affymetrix GeneChip® Microarrays as well as Axiom array plates Supported Quality Systems: CLIA, HIPPA, GCP DMET certified.
Genome Explorations, is a premier research institution providing global genomic profiling and molecular diagnostics services to academic centers, pharmaceutical and biotech industry, oncologists, and pathologists with innovative diagnostic, prognostic, predictive, and personalized testing.
Genpathway is your total solution for ChIP-on-Chip and Methylated DNA IP-on-Chip Assays. These assays, FactorPath™, TranscriptionPath™, and Methylated DNA, represent a powerful combination of Genpathway's high-quality chromatin immunoprecipitation (ChIP) and DNA IP assays with Affymetrix' whole-genome tiling arrays. Genpathway's technologies provide an immediate solution for analyzing gene regulation by transcription factors and co-regulators, gene transcription, and epigenetic changes. Provided as a comprehensive service, each assay includes the complete ChIP/DNA IP procedure from chromatin/DNA preparation to antibody qualification, chromatin/DNA validation, multiple QC steps, use of optimized ChIP/DNA IP protocols, and complete analysis of results in an easy-to-view format.
Neogen Agrigenomics provides comprehensive agrigenomic solutions and services for the agricultural biotechnology industry, and leading companion animal registries. With both GeneSeek® state-of-the-art genetics laboratories and the comprehensive Igenity® bioinformatics to interpret genetic test results, Neogen offers unparalleled identity and trait determination and analysis. GeneSeek is considered the leading commercial agricultural genetics service laboratory in the United States. Igenity has helped develop an extensive bioinformatics system to identify and predict beef cattle positive or negative traits based on DNA test results.
Open Medicine Institute
The Open Medicine Institute (OMI) is an independent research institute and laboratory service provider. OMI provides a range of the most advanced -omic research laboratory testing available (internally or with academic and industry partners) including microbiome, gene expression, microRNA analysis, microarrays, DNA sequencing, metabolomics, proteomics, PCR, immunologic cell analyses and more. As an authorized service provider of Affymetrix, OMI provides core services around all Affymetrix arrays (catalog and custom) as well as contract development laboratory work around Affymetrix products. OMI is a leader in precision medicine for laboratories and clinical activities. OMI's services are supported by OpenMedNet, a secure cloud for integrating research, clinical, patient, and -omic data.
Precision Biomarker Resources
Precision Biomarker Resources provides automated, high-throughput microarray services using the latest Affymetrix GeneChip Microarray platform to expedite the biologic investigations of pharmaceutical, biotechnology and academic researchers.
Response Genetics, Inc.
Response Genetics is a world leading company in the analysis of formalin fixed paraffin embedded tissue (FFPE) with laboratories in both North America and Europe. Response Genetics is an Affymetrix authorized service provider for FFPE tissue with the capability of analyzing microdissected tissue for gene expression by microarray (U133 plus 2.0). The company's laboratories are GLP-compliant and CLIA certified (U.S.) for handling patient samples.
Reveal Biosciences is a leading provider of advanced tissue technology services and tissue-based research. Their portfolio includes in situ hybridization (ISH), immunohistochemistry (IHC), immunofluorescence (IF), and histology. Reveal enhances these services with proprietary technologies for NGPx™ Next Generation Pathology, multiplexing, whole slide imaging, and ImageDx™ image analysis software as a service.
Second Genome, Inc.
Second Genome is unlocking the promise of the microbiome, providing unparalleled capabilities for life science researchers to easily and quickly identify and understand microbial signatures of human disease. Accomplishing in weeks what can take months or years on your own, our service utilizes a combination of proven and proprietary assay technologies for simultaneously measuring the entire microbiome, novel bridging technologies and advanced informatics.
SeqWright Incorporated is a world-class genomic services support organization based in Houston, TX with more than a decade of experience specializing in providing access to state of the art Molecular Biology and Genomic services in a highly regulated GLP/CLIA environment (CLIA and GLP compliant*).
*These Affymetrix service providers state that they have met the FDA requirements associated with 21 CFR Part 58 and are in compliance with Good Laboratory Practices (GLP). Please note: Affymetrix has not performed independent verification of these statements and makes no representation or warranty regarding the validity of any such statement.